Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

AYTU holding history

Aytu Biopharma, Inc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AYTU overviewAll 13F holders of AYTUFull Q2 2026 holdings

Shares (Q2 2026)
2,377
Value
$5.11K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AYTU by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,377$5.11K<0.1%+714+42.9%AddedHolders
Q1 20261,663$4.54K<0.1%−1,386−45.5%ReducedHolders
Q4 20253,049$7.93K<0.1%−86−2.7%ReducedHolders
Q3 20253,135$5.89K<0.1%+88+2.9%AddedHolders
Q2 20253,047$6.64K<0.1%+2,785+1,063.0%AddedHolders
Q1 2025262$314<0.1%−1,234−82.5%ReducedHolders
Q4 20241,496$2.54K<0.1%+1,236+475.4%AddedHolders
Q3 2024260$611<0.1%−48−15.6%ReducedHolders
Q2 2024308$899<0.1%−718−70.0%ReducedHolders
Q1 20241,026$3.12K<0.1%+766+294.6%AddedHolders
Q4 2023260$738<0.1%−3,904−93.8%ReducedHolders
Q3 20234,164$11.2K<0.1%+3,904+1,501.5%AddedHolders
Q2 2023260$416<0.1%−5,013−95.1%ReducedHolders
Q1 20235,273$11.8K<0.1%+5,012+1,921.1%AddedConverted for a 1-for-20 splitHolders
Q4 20225,218$991<0.1%−52,001−90.9%ReducedHolders
Q3 202257,219$11.0K<0.1%+51,088+833.3%AddedHolders
Q2 20226,131$4.00K<0.1%+6,130+613,000.0%AddedHolders
Q1 20221$00.0%−14,631−100.0%ReducedHolders
Q4 202114,632$20.0K<0.1%+13,050+824.9%AddedHolders
Q3 20211,582$5.00K<0.1%+663+72.1%AddedHolders
Q2 2021919$5.00K<0.1%−1,743−65.5%ReducedHolders
Q1 20212,662$20.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.